HealthyDirect · GrowthFit for a long SIP
LIC MF Healthcare Fund
LIC Mutual FundEquity Scheme - Sectoral/ Thematic3.3 years
The Scheme seeks to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors.
- NAV
- 36.0849
- 29 Oct 2026
- 1Y
- +10.1%
- Trailing CAGR
- AUM
- ₹99.36 Cr
- 30 Sept 2026
- Volatility
- Medium
- 14.0% annualized
Buying brief
Should you add this fund?
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 29 Oct 2026
Stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
In three lines
Fits if · The fund beat the category median in 100% of rolling 3-year windows.
Fits if · Three-year return is above the category median.
Buy checklist
History depth
Watch
3.3 years - usable, still building a track record.
Engine status
Pass
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Expense ratio
Pass
1.38% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Pass
Peak-to-trough -15.1%. Ask whether you can hold through a similar fall.
Vs category
Pass
100% of rolling 3Y windows beat the category median, same plan and option.
Manager tenure
Watch
Dhaval Sangoi · 0.2 years on the scheme.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Watch
Top 10 holdings ≈ 60.2% of the portfolio.
Evidence supports a shortlist - confirm with peers before you buy elsewhere.
Before you buy or SIP
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 15%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
If you start a SIP here, diary a 90-day check and an annual review - don’t react to every NAV print.
NAV
Path not in current snapshots
n/a
Returns
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
- 1Y+10.1%
- 3Y+22.3%
- 5Yn/a
- 10Yn/a
- SI+19.5%
SIP XIRR
Equal monthly instalments to latest NAV
- 1Y+16.3%
- 3Y+13.3%
- 5Yn/a
- 10Yn/a
- Since inception
- +19.5%
- Calendar-day CAGR
- Excess 1Y
- +12.9%
- Category median, same plan and option
- 3Y win rate
- +100%
- Windows beating the median
- 3Y percentile
- 91
- Vs comparable share classes
- SIP 3Y XIRR
- +13.3%
- Simulated monthly SIP
- Worst rolling 3Y
- +19.7%
- 62 daily-ending windows
- Median rolling 3Y
- +22.2%
- Calendar-day CAGR
- Positive rolling 5Y
- n/a
- 0 daily-ending windows
Drawdown
Peak to trough from a running NAV high, with the path and recovery episodes.
- Max drawdown
- -15.1%
- Worst peak-to-trough
- Current
- -6.2%
- Below last peak
- Current spell
- 59 days
- Days below latest peak
- Time below peak
- +86%
- NAV observations
Drawdown
Path not in current snapshots
n/a
- Average recovery
- 13 days
- 48 recovered episodes
- Longest recovery
- 432 days
- Trough to prior peak
5 Dec 2024 – 6 May 2026
Trough 28 Feb 2025 · recovered in 432 days
-15.1%
31 Aug 2026 – open
Trough 23 Oct 2026 · not recovered
-11.0%
9 Aug 2023 – 8 Nov 2023
Trough 26 Oct 2023 · recovered in 13 days
-6.6%
16 Oct 2024 – 3 Dec 2024
Trough 18 Nov 2024 · recovered in 15 days
-5.5%
Dimensions
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
92
Vs category
100
Consistency
89
Risk-adjusted
72
Drawdown
62
Mean
83
Decision
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Healthy
Buying stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Why this status
- No material deterioration, cost shock, or persistent category underperformance in the current evidence set.
Supporting reads
- The fund beat the category median in 100% of rolling 3-year windows.
- Three-year return is above the category median.
- Risk-adjusted return sits above the documented risk-free proxy.
Portfolio
30 Sept 2026 · 26 holdings · top 10 are 60.2%.
- Top 5
- 36.6%
- Top 10
- 60.2%
- Largest holding
- 9.6%
- Effective holdings
- 20.0
Sun Pharmaceutical Industries Ltd
Healthcare
9.6%
Divi's Laboratories Ltd
Healthcare
9.1%
Neuland Laboratories Ltd
Healthcare
6.1%
Torrent Pharmaceuticals Ltd
Healthcare
6.0%
Apollo Hospitals Enterprise Ltd
Healthcare
5.8%
Worth investigating
Same-category peers with enough history to inspect beside this fund - including tradeoffs.
Sundaram Multi-Factor Fund
Sundaram Mutual Fund
- 1Y
- -9.4%
- 3Y
- n/a
- Vol
- 13.6%
- Max DD
- -14.9%
- Sharpe
- -0.73
- 3Y win
- n/a
- Lower volatility
- Shallower drawdown
Caveat: Higher TER · Lower trailing returns
ICICI PRUDENTIAL HOUSING OPPORTUNITIES FUND
ICICI Prudential Mutual Fund
- 1Y
- -9.1%
- 3Y
- +10.7%
- Vol
- 12.6%
- Max DD
- -16.7%
- Sharpe
- 0.55
- 3Y win
- +65%
- Lower volatility
- Lower TER
Caveat: Deeper drawdown · Lower trailing returns
Kotak Business Cycle Fund
Kotak Mahindra Mutual Fund
- 1Y
- +0.3%
- 3Y
- +16.1%
- Vol
- 12.7%
- Max DD
- -18.4%
- Sharpe
- 0.72
- 3Y win
- +98%
- Lower volatility
- Lower TER
Caveat: Deeper drawdown · Lower trailing returns
Aditya Birla Sun Life Business Cycle Fund
Aditya Birla Sun Life Mutual Fund
- 1Y
- +0.1%
- 3Y
- +13.1%
- Vol
- 13.9%
- Max DD
- -17.8%
- Sharpe
- 0.39
- 3Y win
- +13%
- Lower volatility
Caveat: Deeper drawdown · Higher TER · Lower trailing returns
Baroda BNP Paribas Energy Opportunities Fund
Baroda BNP Paribas Mutual Fund
- 1Y
- -6.6%
- 3Y
- n/a
- Vol
- 13.9%
- Max DD
- -16.1%
- Sharpe
- 0.04
- 3Y win
- n/a
- Lower volatility
Caveat: Deeper drawdown · Higher TER · Lower trailing returns